PortfoliosLab logo

BriaCell Therapeutics Corp. (BCT.TO)

Equity · Currency in CAD · Last updated Aug 6, 2022

Company Info

ISINCA10778Y3023
CUSIP10778Y302
SectorHealthcare
IndustryBiotechnology

BCT.TOShare Price Chart


Chart placeholderClick Calculate to get results

BCT.TOPerformance

The chart shows the growth of CA$10,000 invested in BriaCell Therapeutics Corp. in Jan 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly CA$603 for a total return of roughly -93.97%. All prices are adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%60.00%MarchAprilMayJuneJulyAugust
-5.34%
-9.93%
BCT.TO (BriaCell Therapeutics Corp.)
Benchmark (^GSPC)

BCT.TOReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M5.96%8.50%
6M4.27%-9.80%
YTD-19.43%-15.80%
1Y35.34%-9.14%
5Y-31.93%6.10%
10Y-23.24%7.42%

BCT.TOMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-24.06%19.01%32.67%-29.03%-29.93%16.46%13.86%1.91%
2021-8.19%-22.40%13.85%-7.01%-11.09%65.59%-3.31%32.55%21.15%-3.20%27.15%-16.47%
2020104.58%-22.40%-43.31%3.24%-10.49%-38.88%56.56%-24.61%-19.86%-6.07%-11.62%24.84%
20196.25%23.53%9.52%-30.43%18.75%-15.79%-18.75%-7.69%0.00%-16.67%-20.00%0.00%
2018-12.50%-21.43%18.18%-15.38%9.09%25.00%-10.00%-14.81%13.04%-15.38%-4.55%-23.81%
2017-10.00%30.56%-10.64%-9.52%-2.63%-8.11%-5.88%6.25%-20.59%3.70%-10.71%28.00%
2016-14.29%-28.57%86.67%-28.57%-7.50%-2.70%27.78%-13.04%22.50%-20.41%-20.51%29.03%
201511.11%-22.50%48.39%32.61%3.28%-23.81%-4.17%2.17%-0.00%17.02%-20.00%11.36%
201420.02%33.37%25.02%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%10.50%
201312.51%-22.24%-14.30%-16.68%40.05%-14.30%0.00%0.00%-16.68%0.00%20.02%-16.68%
201210.01%-15.16%-3.57%-3.68%0.00%-30.77%-22.24%-14.30%-8.29%18.14%-30.75%-11.12%
2011-10.26%-8.58%0.00%90.64%-16.40%-21.57%2.50%-43.90%-47.82%66.67%-40.00%24.99%
201093.12%-25.01%4.77%15.91%-31.37%-25.70%-19.24%4.77%118.20%54.16%-2.70%8.34%

BCT.TOSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current BriaCell Therapeutics Corp. Sharpe ratio is 0.41. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.001.50MarchAprilMayJuneJulyAugust
0.41
-0.44
BCT.TO (BriaCell Therapeutics Corp.)
Benchmark (^GSPC)

BCT.TODividend History


BriaCell Therapeutics Corp. doesn't pay dividends

BCT.TODrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugust
-98.57%
-16.05%
BCT.TO (BriaCell Therapeutics Corp.)
Benchmark (^GSPC)

BCT.TOWorst Drawdowns

The table below shows the maximum drawdowns of the BriaCell Therapeutics Corp.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the BriaCell Therapeutics Corp. is 99.40%, recorded on May 19, 2021. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.4%May 2, 20111942May 19, 2021
-69.7%Apr 19, 201041Jul 5, 201040Oct 7, 201081
-51.72%Oct 18, 201020Nov 15, 2010103Apr 29, 2011123
-29.3%Jan 29, 20107Feb 10, 201034Apr 15, 201041
-7.59%Oct 13, 20101Oct 13, 20101Oct 14, 20102
-3.45%Jan 12, 20101Jan 12, 20101Jan 18, 20102

BCT.TOVolatility Chart

Current BriaCell Therapeutics Corp. volatility is 33.10%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%MarchAprilMayJuneJulyAugust
33.10%
19.27%
BCT.TO (BriaCell Therapeutics Corp.)
Benchmark (^GSPC)